Yanik S, Venkatesh V, Gordy J, Alameh M, Meza J, Li Y
NPJ Vaccines. 2025; 10(1):34.
PMID: 39971939
PMC: 11840135.
DOI: 10.1038/s41541-025-01089-x.
Lukeman H, Al-Wassiti H, Fabb S, Lim L, Wang T, Britton W
EBioMedicine. 2025; 113:105599.
PMID: 39955975
PMC: 11871481.
DOI: 10.1016/j.ebiom.2025.105599.
Yun J, Shin E, Lee Y, Lee J, Lee H, Kim J
Front Microbiol. 2025; 16:1492268.
PMID: 39927262
PMC: 11802578.
DOI: 10.3389/fmicb.2025.1492268.
Farroni C, Altera A, Salmi A, Vanini V, Cuzzi G, Arlehamn C
Front Immunol. 2025; 15:1484143.
PMID: 39872515
PMC: 11770028.
DOI: 10.3389/fimmu.2024.1484143.
Park S, Kim Y, Lee H, Han J, Seo B, Park G
Virulence. 2025; 16(1):2453818.
PMID: 39831520
PMC: 11749362.
DOI: 10.1080/21505594.2025.2453818.
Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.
Lopes K, Freire M, Murta S, Oliveira E
PLoS Negl Trop Dis. 2024; 18(12):e0012757.
PMID: 39739955
PMC: 11753665.
DOI: 10.1371/journal.pntd.0012757.
Epstein-Barr virus-specific T-cell response in pediatric liver transplant recipients: a cross-sectional study by multiparametric flow cytometry.
Cuesta-Martin de la Camara R, Torices-Pajares A, Miguel-Berenguel L, Reche-Yebra K, Frauca-Remacha E, Hierro-Llanillo L
Front Immunol. 2024; 15:1479472.
PMID: 39512353
PMC: 11540634.
DOI: 10.3389/fimmu.2024.1479472.
A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles.
Karan S, de Oliveira J, Moreno-Gonzalez M, Steinmetz N
ACS Appl Bio Mater. 2024; 7(11):7675-7683.
PMID: 39512153
PMC: 11648571.
DOI: 10.1021/acsabm.4c01239.
Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.
Snow B, Keles N, Grunst M, Janaka S, Behrens R, Evans D
PLoS Pathog. 2024; 20(10):e1012665.
PMID: 39466835
PMC: 11542898.
DOI: 10.1371/journal.ppat.1012665.
Effect of RTS,S/AS01 vaccine booster dose on cellular immune responses in African infants and children.
Mitchell R, Macia D, Jairoce C, Mpina M, Naidu A, Chopo-Pizarro A
NPJ Vaccines. 2024; 9(1):200.
PMID: 39455625
PMC: 11511852.
DOI: 10.1038/s41541-024-00977-y.
A multivalent mRNA-LNP vaccine protects against infection.
Alameh M, Semon A, Bayard N, Pan Y, Dwivedi G, Knox J
Science. 2024; 386(6717):69-75.
PMID: 39361752
PMC: 11719173.
DOI: 10.1126/science.adn4955.
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection.
Atochina-Vasserman E, Lindesmith L, Mirabelli C, Ona N, Reagan E, Brewer-Jensen P
NPJ Vaccines. 2024; 9(1):182.
PMID: 39353926
PMC: 11445234.
DOI: 10.1038/s41541-024-00976-z.
A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.
Kent J, Klug L, Heinrich M
Clin Cancer Res. 2024; 30(23):5399-5412.
PMID: 39321216
PMC: 11611653.
DOI: 10.1158/1078-0432.CCR-24-1601.
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.
Gangaev A, van Sleen Y, Brandhorst N, Hoefakker K, Prajapati B, Singh A
Front Immunol. 2024; 15:1447555.
PMID: 39257577
PMC: 11385311.
DOI: 10.3389/fimmu.2024.1447555.
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications.
Bliss C, Hulin-Curtis S, Williams M, Maruskova M, Davies J, Statkute E
Mol Ther Methods Clin Dev. 2024; 32(3):101308.
PMID: 39206304
PMC: 11357811.
DOI: 10.1016/j.omtm.2024.101308.
Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded protein of circovirus.
Lu C, Li H, Chen W, Li H, Ma J, Peng P
Front Immunol. 2024; 15:1438371.
PMID: 39081314
PMC: 11286414.
DOI: 10.3389/fimmu.2024.1438371.
Immunizing Mice with Influenza Virus-like Particles Expressing the Promastigote Surface Antigen Alleviates Inflammation in Footpad.
Eom G, Chu K, Yoon K, Mao J, Kim S, Quan F
Vaccines (Basel). 2024; 12(7).
PMID: 39066431
PMC: 11281337.
DOI: 10.3390/vaccines12070793.
Immature dendritic cell-targeting mRNA vaccine expressing PfCSP enhances protective immune responses against liver infection.
Yanik S, Venkatesh V, Gordy J, Gabriel-Alameh M, Meza J, Li Y
Res Sq. 2024; .
PMID: 39041038
PMC: 11261966.
DOI: 10.21203/rs.3.rs-4656309/v1.
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.
Izadi A, Godzwon M, Soderlund Strand A, Schmidt T, Kumlien Georen S, Drosten C
J Immunol. 2024; 213(5):678-689.
PMID: 39018495
PMC: 11335326.
DOI: 10.4049/jimmunol.2300675.
Dysfunctional host cellular immune responses are associated with mortality in melioidosis.
Wright S, Ekchariyawat P, Sengyee S, Phunpang R, Dulsuk A, Saiprom N
Emerg Microbes Infect. 2024; 13(1):2380822.
PMID: 39008280
PMC: 11293272.
DOI: 10.1080/22221751.2024.2380822.